BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10586440)

  • 1. [Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage].
    Marie I; Lévesque H; Hatron PY; Dominique S; Courtois H
    Rev Med Interne; 1999 Nov; 20(11):1017-27. PubMed ID: 10586440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac and pulmonary involvement in scleroderma].
    Launay D; Hachulla E
    Rev Prat; 2002 Nov; 52(17):1901-7. PubMed ID: 12532867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in systemic sclerosis.
    Denton CP; Black CM
    Rheum Dis Clin North Am; 2003 May; 29(2):335-49, vii. PubMed ID: 12841298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung involvement in systemic sclerosis.
    Hassoun PM
    Presse Med; 2011 Jan; 40(1 Pt 2):e3-e17. PubMed ID: 21195581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cyclically iloprost infusion prevent severe isolated pulmonary hypertension in systemic sclerosis? Preliminary results.
    Caramaschi P; Volpe A; Tinazzi I; Bambara LM; Carletto A; Biasi D
    Rheumatol Int; 2006 Dec; 27(2):203-5. PubMed ID: 17006704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis.
    Ahmadi-Simab K; Köhler A; Gross WL
    Clin Exp Rheumatol; 2007; 25(5):760-2. PubMed ID: 18078629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung disease in systemic sclerosis (scleroderma).
    Bolster MB; Silver RM
    Baillieres Clin Rheumatol; 1993 Feb; 7(1):79-97. PubMed ID: 8519079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worsening gradient of aortic stenosis with treatment of pulmonary arterial hypertension in scleroderma.
    Pietras DA; Lopez FR; Peréz R; López-Candales A; Elwing J
    Bol Asoc Med P R; 2015; 107(1):41-4. PubMed ID: 26035984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease].
    Marie I; Lévesque H; Dominique S; Hatron PY; Michon-Pasturel U; Remy-Jardin M; Courtois H
    Rev Med Interne; 1999 Nov; 20(11):1004-16. PubMed ID: 10586439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis complicated by diffuse alveolar hemorrhage.
    Chaer RA; Massad MG; Evans A; Olopade C; Varga J
    Med Sci Monit; 2001; 7(5):1013-5. PubMed ID: 11535951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary involvements in patients with collagen disease].
    Endo H
    Nihon Rinsho; 2009 Mar; 67(3):536-41. PubMed ID: 19280929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary involvement in systemic sclerosis.
    Shahin AA
    Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary involvement in systemic scleroderma].
    Guillevin L; Mouthon L
    Bull Acad Natl Med; 2011 Jan; 195(1):79-90; discussion 90-2. PubMed ID: 22039705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis.
    Griffin MT; Robb JD; Martin JR
    Thorax; 1990 Nov; 45(11):903-4. PubMed ID: 2256025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary involvement in progressive systemic sclerosis].
    Grisanti M; Vicencio M
    Rev Med Chil; 1986 Oct; 114(10):1002-5. PubMed ID: 3575934
    [No Abstract]   [Full Text] [Related]  

  • 19. New insights into the recognition, classification and management of systemic sclerosis-associated pulmonary hypertension.
    Mullin CJ; Mathai SC
    Curr Opin Rheumatol; 2017 Nov; 29(6):561-567. PubMed ID: 28817465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
    Menon N; McAlpine L; Peacock AJ; Madhok R
    Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.